Gregoire Courtine, PhD, Swiss Federal Institute of Technology.
Grégoire Courtine was trained in Mathematics, Physics, and Neurosciences. He received his PhD degree in Experimental Medicine from the Inserm Plasticity and Repair, France, in 2003. After a Post-doctoral training at the University of California (UCLA), where he was also an associate researcher for the Christopher and Dana Reeve Foundation, he established his own laboratory at the University of Zurich in 2008. He received the Schellenberg Prize for his work in paraplegia and a fellowship from the European Research Council in 2009 for the significant progress made in the development of neurotechnologies. In 2012, he accepted the International Paraplegic Foundation (IRP) chair in Spinal Cord Repair in the Center for Neuroprosthetics at the Swiss Federal Institute of Technology, Lausanne (EPFL). Over the past 15 years, Prof Courtine has implemented an unconventional research program with the aim to develop radically new treatment paradigms to improve motor function in severely paralyzed people. The results of this research were recognized in various high-profile publications such as Science and Nature journals. In 2013, he was invited to share his personal and scientific journey at TEDGlobal. In 2014, Grégoire launched his startup, G-Therapeutics SA, which aims to translate his medical and technological breakthroughs into therapeutic treatments. His startup obtained numerous prizes. In parallel, he set up an innovative Gait Rehabilitation Platform at the University Hospital of Vaud (CHUV) to implement clinical trials.
- An integrated in silico pipeline identifies a novel TF combination that promotes enhanced CST growth following injury
- Spike timing-dependent plasticity in the adult rat with chronic cervical spinal cord contusion
- Effect of PTEN antagonist peptide on the functional motor recovery in rat
- GDF10 promotes axonal regeneration and functional recovery: A novel gene therapy strategy for spinal cord injury
- GTX Medical and NeuroRecovery Technologies to merge
- Candidate Therapy From Quebec for Chronic SCI Being Developed in Parallel by Academics and Companies in Switzerland and the Netherlands
- Moving beyond the glial scar for spinal cord repair
- The Struggle to Make CNS Axons Regenerate: Why Has It Been so Difficult?
- The potential of electric field for promoting neurite guidance in spinal cord injury regeneration strategies
- Extraction and selective activation of muscle synergies through spinal stimulation for SCI
- Early limb unloading elicits long-term motor deficits involving motorneuron hyperexcitability associated with persistent alterations in glutamatergic synaptic plasticity in spinal cord injury
- The effects of a pro-angiogenic, RGD-functionalized, nanofiber composite biomaterial on mesenchymal stem cell-mediated repair of the injured spinal cord
- From wheelchair to walking after spinal cord injury
- ReNetX Bio, Inc. Announces U.S. FDA Authorization to Proceed for IND Application to Treat Patients with Chronic Spinal Cord Injury
- Regeneration of Spinal Cord Connectivity Through Stem Cell Transplantation and Biomaterial Scaffolds
Follow on TwitterMy Tweets